How we got Ozempic
Send us Fan MailHow a "Failed" 4-Minute Molecule Created a Trillion-Dollar Cultural EclipseImagine pitching a drug to a room of venture capitalists that is biologically perfect—except for one tiny flaw: the human body co...
Podcast Index
Podcasts
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Tout
Actualités
Politique
Musique
Sport
Technologie
Comédie
Arts
Business
Éducation
Fiction
Gouvernement
Santé & fitness
Histoire
Enfants & famille
Loisirs
Religion & spiritualité
Science
Société & culture
True crime
TV & cinéma
DarshanTalks Podcast
Darshan Kulkarni
The Lifeonaire Show
Lifeonaire.com
Addiction Unlimited Podcast
Angela Pugh
Der Radio TEDDY-Nachrichtenpodcast des Tages
Radio TEDDY
P2P Cafe - Der P2P Kredite Talk mit Thomas Butz & Lars Wrobbel #123
Thomas Butz & Lars Wrobbel
The xMonks Drive
Gaurav Arora
Tony Robbins Podcast Daily
Tony
TuttoLibri
Radio Number One
Funny Medicine Podcast
Julia Brunet and Yvette Gonzalez, D.O.
4REX | Trading Talk
Tom von 4REX Impulse
Hypnosis for sleeping deeply (Jason Newland)
Jason Newland
Hello Seven Podcast
Rachel Rodgers
Der immocation Podcast | Lerne Immobilien
immocation
Keeping It Real: Conversations with Jillian Michaels
Jillian Michaels
Life Point
Tom Dougherty
Evidence 4 Faith
Michael Lane
Show Me The Money Club
Sergio and Chris
Dance To Heal Podcast
Jenny C. Cohen
Designing with Love
Jackie Pelegrin
Restart Hope
Joel Sikha
Big Talk About Small Business
Big Talk About Small Business
Gardening Inside Out
Gardening Inside Out
Salon Success Secrets — The podcast for salon owners who are done hustling harder and ready to break their revenue ceiling.
Lindsay Lowe & Jen Booth
Shane Hewitt and The Nightshift
iHeartRadio
Australian Daily Tanya with R' Yossi Paltiel
Inside Chassidus
Practical Advice from the Scriptures
Anissa Cooke
OK Let’s Learn
Kevin OKeefe
7 Good Minutes
Clyde Lee Dennis
Republic Broadcasting Network
Republic Broadcasting Network
Jak Piggott
Jak Piggott
Seeds of Revolution
Camas Books and Infoshop
Relax & sleep hypnosis daily
Jason Newland
Lifelong Learning With A. A. Khatana
A.A. Khatana
Simply Charlotte Mason Homeschooling (video)
Sonya Shafer
Simply Charlotte Mason Homeschooling
Sonya Shafer
Kryptonite
Eric Zuzack
The Independent Advisors
Mark McEvily
Éducation
DarshanTalks Podcast
Darshan Kulkarni
Unlicensed Medical Advice & The Legal Battle Over Character.AI
Send us Fan MailWhat happens when an artificial intelligence chatbot generates a fake medical license number and starts giving psychiatric advice?In this episode of the KF Deep Dive, host Darshan welcomes healthcare regu...
Sponsoring Cannabis Research
Send us Fan Mail NOT LEGAL ADVICE For decades, cannabis research in the U.S. was stifled by Schedule I restrictions, requiring high-security vaults, mountains of paperwork, and extremely limited supply chains. With Execu...
The New Era of Personal Consent Decrees
Send us Fan MailIs your career protected from your company’s mistakes? For decades, a Federal Consent Decree was a corporate headache. Today, it’s a personal professional death sentence. In this episode, Darshan Kulkarni...
Why Private Membership Associations Fail FDA Scrutiny
Send us Fan Mail In this episode of the KLF Deep Dive, Darshan Kulkarni deconstructs a persistent and dangerous myth circulating in life sciences and investment circles: the Private Membership Association (PMA). While of...
The Hidden Reason Sites are Firing Recruiters
Send us Fan Mail What would happen if your clinical trial sites were suddenly banned from using you? In this episode, Darshan Kulkarni uncovers a hidden regulatory shift: state licensing boards are tightening the "Corpor...
Don’t Let Your PI Walk Away With Your Study
Send us Fan Mail In this tactical masterclass, Darshan Kulkarni breaks down the critical legal architecture required to protect clinical trial sites during rapid expansion. As PIs and Sub-Investigators move between organ...
Safe or Just "Not Dirty"? The Regulatory Gamble of Compounded Drugs
Send us Fan Mail In this episode, Darshan Kulkarni breaks down the staggering legal difference between the branded drugs you know (like Mounjaro) and the compounded versions flooding the market. Using a brilliant "Coke v...
"Basically Employees" Isn't a Legal Category (And the OIG Knows It)
Send us Fan MailStop playing compliance theater. In this episode, Darshan Kulkarni pulls back the curtain on a dangerous trend in the life sciences: the over-reliance on contract sales forces without the legal control to...
The Hidden Legal Risks of AI Sponsor Protocols
Send us Fan Mail Is AI the savior of clinical research costs, or a ticking time bomb for data integrity? In this episode, Darshan Kulkarni dives into the murky waters of AI-driven sponsor protocols. We explore how AI is ...
The $100M Mistake: Why AI-Generated Drugs May Not Be Patentable
Send us Fan Mail"The model said so" is not a defense. In the rush to integrate AI into drug discovery, life science companies are sprinting toward a compliance cliff. In this episode, Darshan Kulkarni—pharmacist and FDA ...
Is AI replacing your Doctor?
Send us Fan MailIn this episode of DarshanTalks, host and attorney-pharmacist Darshan Kulkarni explores the unsettling transition from "Googling your symptoms" to "Chatting with your symptoms." It’s 10:47 PM—you have che...
Why the OIG Just Revolutionized Pharma Marketing (And What It Costs You)
Send us Fan Mail On January 27, 2026, the HHS Office of Inspector General (OIG) changed the game for pharmaceutical manufacturers. In a landmark Special Advisory Bulletin, the government officially opened a "green lane" ...
6 Categories of "Bulk Data" That Could Land You in Federal Court.
Send us Fan MailThe DOJ just changed the rules of the game for the Life Sciences industry. As of January 2025, transferring "Bulk Sensitive Personal Data" to countries of concern—specifically China—is no longer just a co...
The Utah Experiment: The Dangerous New Frontier of AI Prescribing
Send us Fan MailIs your state "sandbox" a playground or a legal minefield? In this episode, Darshan Kulkarni—pharmacist and attorney—dissects the quiet movement of states like Utah allowing AI to manage and renew prescri...
Is Your DTC Program a Kickback Trap?
Send us Fan Mail The OIG has officially shifted the goalposts for Direct-to-Consumer (DTC) and Direct-to-Patient (DTP) programs. For years, federal healthcare discounts were a "no-go zone," but a new dual-track strategy ...
The Hidden Death Sentence for Trial Sites
Send us Fan Mail In this episode of KLF Deep Dive, Darshan Kulkarni uncovers the catastrophic risks clinical trial sites face when they fail to vet their staff against federal exclusion lists. We move beyond simple compl...
FDA "Screams": The Real Reason Your Snack Is At Risk
Send us Fan MailUndeclared allergens remain the #1 cause of food recalls in the U.S., yet many brands still treat labeling as a "marketing" task rather than a "legal" one. In this episode of KLF Deep Dive, Darshan Kulkar...
2 Laws More Dangerous Than HIPAA for Patient Engagement
Send us Fan Mail Think HIPAA is your biggest hurdle in pharma marketing? Think again. In this episode of KLF Deep Dive, Darshan Kulkarni reveals why focusing solely on HIPAA leaves a massive, unregulated gap in your comp...
"Invite-Only" Compliance Is Over: Is Your Cosmetic Company Ready?
Send us Fan Mail The "handshake" era of cosmetic compliance is officially over. Under new authorities in Sections 605, 610, and 704, the FDA has moved from simple observation to an aggressive "access and copy" mandate. I...